Home > Healthcare > Pharmaceuticals > Drug Delivery > Nanotechnology-based Drug Delivery Market
Nanotechnology-based Drug Delivery Market Share
- Report ID: GMI6208
- Published Date: Jul 2023
- Report Format: PDF
Nanotechnology-based Drug Delivery Market Share
Major market players operating in the nanotechnology-based drug delivery market include:
- AbbVie Inc.
- BlueWillow Biologics Inc.
- Camurus AB
- Celgene, Inc.
- Cristal Therapeutics
- EyePoint Pharmaceuticals
- Johnson
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Frequently Asked Questions (FAQ) :
Global market for nanotechnology-based drug delivery accounted for USD 95.2 billion in 2022 and is estimated to grow at a CAGR of 12.6% through 2032, owing to the growing preference for precision medicines.
Nanoparticles technology segment will grow at 12.4% CAGR through 2032. Continuous advancements in nanomaterials have led to the development of a diverse range of nanoparticle platforms, thereby offering flexibility and versatility in drug delivery applications.
North America market for nanotechnology-based drug delivery accounted for 46.6% revenue share in 2022 and will grow at considerable rate in the coming years, backed by the increasing prevalence of chronic diseases, a high disposable income, and robust healthcare infrastructure.
AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, Inc., Cristal Therapeutics, EyePoint Pharmaceuticals, and Johnson and Johnson, among others.
Nanotechnology-based Drug Delivery Market Scope
×
Get a free sample of
Nanotechnology-based Drug Delivery Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below